Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months / 대한생식의학회지
Clinical and Experimental Reproductive Medicine
; : 215-220, 2016.
Article
在 En
| WPRIM
| ID: wpr-54500
Responsible library:
WPRO
ABSTRACT
OBJECTIVE:
To evaluate the efficacy and safety of dienogest treatment in patients who had received dienogest for 12 months or more to treat endometriosis.METHODS:
We analyzed the clinical data of 188 women with endometriosis who had been treated with 2 mg of dienogest once a day for 12 months or more at a single institute. We evaluated changes in endometriosis-associated pain and endometrioma size, recurrence rate, and adverse events following dienogest administration. Bone mineral density (BMD) was measured in patients who were prescribed dienogest for more than 18 months.RESULTS:
Pain was significantly reduced at 12 months after dienogest medication. In those treated with dienogest due to recurrent endometrioma, the size of the endometrioma was significantly decreased at the 12-month and 18-month follow-ups. We found only one case of sonographic recurrence during dienogest administration among those who were treated postoperatively to prevent recurrence (1 of 114, 0.9%). The most common adverse drug reaction was uterine bleeding (3.2%), and other adverse events were generally tolerable and associated with low discontinuation rates (5.2%). Among the 50 patients in whom BMD was measured, 10 patients (20%) had a Z-score below the expected range for age.CONCLUSION:
The administration of dienogest for a year or more seems to be highly effective in preventing recurrence after surgery, reducing endometriosis-associated pain, and decreasing the size of recurrent endometrioma, with a favorable safety and tolerability profile. However, BMD should be checked in patients on long-term medication due to possible bone loss in some women.Key words
全文:
1
索引:
WPRIM
主要主题:
Recurrence
/
Uterine Hemorrhage
/
Bone Density
/
Follow-Up Studies
/
Ultrasonography
/
Long-Term Care
/
Drug-Related Side Effects and Adverse Reactions
/
Endometriosis
/
Observational Study
研究类型:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
限制:
Female
/
Humans
语言:
En
期刊:
Clinical and Experimental Reproductive Medicine
年:
2016
类型:
Article